City
Epaper

Metabolic syndrome linked to increased risk of second stroke, death: Study

By ANI | Published: July 29, 2021 6:59 PM

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis.

Open in App

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis.

The findings of the analysis were published in the online issue of Neurology, the medical journal of the American Academy of Neurology.

Metabolic syndrome was defined as having excess belly fat plus two or more of the following risk factors: high blood pressure, higher than normal triglycerides (a type of fat found in the blood), high blood sugar and low high-density lipoprotein (HDL) cholesterol, or "good" cholesterol.

"Studies have shown conflicting results on whether metabolic syndrome, which has been tied to an increased risk of a first stroke, also increases the risk of a second stroke and death, so we wanted to analyze all of the research available," said study author Tian Li, MD, of Fourth Military Medical University in Xi'an, China.

"These findings will help people with metabolic syndrome and their health care providers know that they should be screened for risk of recurrent stroke and given preventative treatments," added Li.

For the risk of stroke recurrence, the meta-analysis combined results from six studies with 11,000 participants who were followed for up to five years. During that time, 1,250 people had a second stroke.

The analysis found that people with metabolic syndrome were 46 per cent more likely to have a second stroke than people who did not have the syndrome.

Looking at each component of metabolic syndrome, researchers found that having a low level of good cholesterol and having two or more components of the syndrome were associated independently with an increased risk of a second stroke.

Having excess belly fat, high blood sugar and high blood pressure were not associated with increased risk of the second stroke on their own.

For the risk of death from any cause, the meta-analysis combined eight studies with 51,613 people who were followed for up to five years. During that time, 4,210 people died.

People with metabolic syndrome were 27 per cent more likely to die during the study than people without the syndrome. None of the individual components of the syndrome was independently associated with an increased risk of death.

"These results add to the evidence that people with metabolic syndrome should take steps to modify their risk of second stroke and even death where possible, through medication, diet, exercise and other recommended lifestyle changes such as stopping smoking," Li said.

Li noted that the studies were observational, so they do not prove that metabolic syndrome is a cause of recurrent stroke or death. They only show an association.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Fourth military medical universityTian liAmerican Academy Of Neurology
Open in App

Related Stories

HealthResearchers reveal inflammatory bowel disease associated with higher risk of stroke

HealthInflammatory bowel disease linked to higher risk of stroke: Research

TechnologyResearchers find staying asleep linked to increased risk of stroke

HealthResearchers reveal seizures while driving, it's important to diagnose epilepsy

HealthExercise may lower Parkinson's disease risk in women by 25%

Health Realted Stories

HealthRare brain infection PAM reported from Kerala, 5-yr-old on put on ventilator

HealthExercise can rejuvenate brain, delay cognitive decline: Study

HealthExplained: The rising burden of dengue in India

HealthBlood proteins that may predict cancer 7 years earlier identified

HealthWHO prequalifies Japanese drug maker Takeda's dengue vaccine